HOME
PRODUCTS
COMPANY
CONTACT
FAQ
Research
Dictionary
Pharma
Sign Up
FREE
or
Login
Username:
Password:
Remember login
Login
Send password reminder...
Marten Trendelenburg Selected Research
Marten Trendelenburg Research Topics
Disease
24
Systemic Lupus Erythematosus (Libman-Sacks Disease)
01/2022 - 11/2005
16
Lupus Nephritis
11/2019 - 11/2005
6
Infections
01/2019 - 02/2007
6
Mannose-Binding Protein Deficiency
01/2013 - 02/2007
4
Nephritis
01/2021 - 11/2006
4
Glomerulonephritis
01/2012 - 11/2005
3
Chronic Obstructive Pulmonary Disease (COPD)
01/2022 - 12/2015
3
COVID-19
01/2021 - 01/2020
3
Reperfusion Injury
01/2019 - 09/2012
2
Disease Progression
07/2022 - 01/2021
2
Muscle Weakness
07/2022 - 11/2011
2
Inflammation (Inflammations)
07/2022 - 01/2012
2
Hypertension (High Blood Pressure)
01/2021 - 09/2008
2
Acute Lung Injury
01/2021 - 01/2021
2
Lymphopenia (Lymphocytopenia)
01/2020 - 08/2017
2
Interstitial Lung Diseases (Interstitial Lung Disease)
01/2020 - 01/2019
2
Agammaglobulinemia (Hypogammaglobulinemia)
01/2020 - 08/2017
2
Ischemia
01/2013 - 01/2011
2
Cryoglobulinemia
01/2012 - 11/2005
2
Proteinuria
01/2012 - 09/2008
2
Virus Diseases (Viral Diseases)
08/2010 - 02/2007
1
Myositis (Idiopathic Inflammatory Myopathies)
07/2022
1
Muscular Diseases (Myopathy)
07/2022
1
Obstructive Lung Diseases (Obstructive Lung Disease)
01/2022
1
IgG Deficiency
08/2021
1
Cardiovascular Diseases (Cardiovascular Disease)
01/2021
1
Chronic Renal Insufficiency
01/2021
1
Lung Diseases (Lung Disease)
01/2021
1
Liver Cirrhosis (Hepatic Cirrhosis)
01/2021
1
Hypersensitivity (Allergy)
01/2021
1
Obesity
01/2021
1
Critical Illness (Critically Ill)
01/2021
1
Fever (Fevers)
11/2020
1
Serositis
11/2020
1
Acute Kidney Injury (Acute Renal Failure)
01/2020
1
Sarcoidosis (Schaumann Disease)
01/2020
1
Pulmonary Fibrosis (Fibrosing Alveolitis)
01/2020
1
Idiopathic Pulmonary Fibrosis
01/2020
1
Thymus Neoplasms (Thymus Neoplasm)
01/2020
1
Hemorrhage
01/2020
1
Cushing Syndrome
01/2020
1
Neuroinflammatory Diseases
01/2019
1
Glioma (Gliomas)
01/2019
1
Systemic Scleroderma (Systemic Sclerosis)
01/2019
Drug/Important Bio-Agent (IBA)
21
Complement System Proteins (Complement)
IBA
01/2021 - 11/2005
20
Autoantibodies
IBA
01/2021 - 05/2006
13
Mannose-Binding Lectin (Mannan-Binding Lectin)
IBA
08/2021 - 02/2007
11
Antibodies
IBA
01/2019 - 11/2005
9
Complement C1q (C1q Complement)
IBA
01/2021 - 11/2005
8
Lectins
IBA
01/2020 - 01/2013
7
Proteins (Proteins, Gene)
FDA Link
01/2021 - 01/2013
6
Immunoglobulin G (IgG)
IBA
01/2022 - 11/2005
5
Complement C1 Inhibitor Protein (C1 Esterase Inhibitor)
IBA
01/2021 - 01/2018
4
Antigen-Antibody Complex (Immune Complex)
IBA
01/2018 - 11/2005
2
Creatine Kinase (Creatine Phosphokinase)
IBA
07/2022 - 11/2011
2
Glucocorticoids
IBA
08/2021 - 11/2020
2
C-Reactive Protein
IBA
01/2021 - 12/2015
2
conestat alfa
IBA
01/2021 - 01/2020
2
Peptides (Polypeptides)
IBA
01/2021 - 11/2012
2
Epitopes
IBA
01/2021 - 11/2012
2
Cystatin C
IBA
01/2020 - 09/2012
2
B-Cell Activating Factor
IBA
11/2019 - 01/2018
2
Antigens
IBA
01/2019 - 12/2009
2
anti-dsDNA autoantibody
IBA
01/2017 - 04/2008
2
Complement Membrane Attack Complex (Membrane Attack Complex)
IBA
09/2014 - 01/2012
2
Thyroid Hormones
IBA
01/2013 - 07/2010
2
Immunosorbents
IBA
11/2012 - 05/2006
2
Enzymes
IBA
11/2012 - 05/2006
2
Cryoglobulins
IBA
01/2012 - 11/2005
2
thiamine triphosphorate (TTP)
IBA
05/2010 - 12/2008
2
Rituximab (Mabthera)
FDA Link
12/2008 - 06/2007
1
Interleukin-6 (Interleukin 6)
IBA
07/2022
1
Biomarkers (Surrogate Marker)
IBA
01/2022
1
Interferons
IBA
01/2022
1
Immunoglobulins (Immunoglobulin)
IBA
08/2021
1
Complement Inactivating Agents
IBA
01/2021
1
Investigational Drugs
IBA
01/2021
1
tocilizumab (atlizumab)
FDA Link
01/2021
1
Interferon Type I
IBA
11/2020
1
Pattern Recognition Receptors
IBA
01/2020
1
Adrenal Cortex Hormones (Corticosteroids)
IBA
01/2020
1
Adrenocorticotropic Hormone (ACTH)
FDA Link
01/2020
1
cenerimod
IBA
01/2020
1
Sphingosine-1-Phosphate Receptors
IBA
01/2020
1
Neopterin
IBA
01/2020
1
asialo-von Willebrand Factor
IBA
01/2020
1
Apolipoprotein A-I (Apolipoprotein A1)
IBA
01/2020
1
N-Methyl-D-Aspartate Receptors (NMDA Receptors)
IBA
01/2019
1
1,3-dipropyl-8-phenylxanthine
IBA
01/2019
1
Acids
IBA
01/2019
1
Dipeptidyl-Peptidases and Tripeptidyl-Peptidases
IBA
01/2019
1
gamma-Aminobutyric Acid (GABA)
IBA
01/2019
1
Glutamate Decarboxylase (Decarboxylase, Glutamate)
IBA
01/2019
1
Leucine (L-Leucine)
FDA Link
01/2019
1
Glycine Receptors (Glycine Receptor)
IBA
01/2019
Therapy/Procedure
1
Duration of Therapy
08/2021
1
Artificial Respiration (Mechanical Ventilation)
01/2021
1
Noninvasive Ventilation
01/2021
1
Contraindications
01/2021
1
Aftercare (After-Treatment)
11/2019